{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T23:10:23Z","timestamp":1789945823971,"version":"4.0.1"},"reference-count":52,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2019,9,12]],"date-time":"2019-09-12T00:00:00Z","timestamp":1568246400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Microbiol."],"DOI":"10.3389\/fmicb.2019.02130","type":"journal-article","created":{"date-parts":[[2019,9,12]],"date-time":"2019-09-12T04:28:31Z","timestamp":1568262511000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":31,"title":["Two New 1,3,4-Oxadiazoles With Effective Antifungal Activity Against Candida albicans"],"prefix":"10.3389","volume":"10","author":[{"given":"Isis Regina Grenier","family":"Capoci","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karina Mayumi","family":"Sakita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniella Renata","family":"Faria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franciele Abigail Vilugron","family":"Rodrigues-Vendramini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Glaucia Sayuri","family":"Arita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Admilton Gon\u00e7alves","family":"de Oliveira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Sueli","family":"Felipe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernard","family":"Maigret","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia de Souza","family":"Bonfim-Mendon\u00e7a","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erika Seki","family":"Kioshima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Terezinha Inez Estivalet","family":"Svidzinski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2019,9,12]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0142926","article-title":"Identification of new antifungal compounds targeting thioredoxin reductase of Paracoccidioides genus.","volume":"10","author":"Abadio","year":"2015","journal-title":"PLoS One"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2164-12-75","article-title":"Comparative genomics allowed the identification of drug targets against human fungal pathogens.","volume":"12","author":"Abadio","year":"2011","journal-title":"BMC Genomics"},{"key":"B3","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1080\/13693780500138971","article-title":"An update on antifungal targets and mechanisms of resistance in Candida albicans.","volume":"43","author":"Akins","year":"2005","journal-title":"Med. Mycol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"6102","DOI":"10.1046\/j.1432-1327.2000.01701.x","article-title":"Physiological functions of thioredoxin and thioredoxin reductase.","volume":"267","author":"Arn\u00e9r","year":"2000","journal-title":"Eur. J. Biochem."},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1097\/TXD.0000000000000673","article-title":"Invasive Candida infections in liver transplant recipients: clinical features and risk factors for mortality.","volume":"3","author":"Bassetti","year":"2017","journal-title":"Transplant. Direct."},{"key":"B6","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1517\/13543776.2011.551116","article-title":"Novel small molecules for the treatment of infections caused by Candida albicans: a patent review (2002\u20132010).","volume":"21","author":"Calugi","year":"2011","journal-title":"Expert Opin. Ther. Pat."},{"key":"B7","year":"2008","journal-title":"Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeasts; Approved Standard\u2013Second Edition, CLSI document M27-A3."},{"key":"B8","doi-asserted-by":"publisher","first-page":"1489","DOI":"10.1007\/s00134-014-3400-y","article-title":"Prognostic factors and historical trends in the epidemiology of candidemia in critically ill patients: an analysis of five multicenter studies sequentially conducted over a 9-year period.","volume":"40","author":"Colombo","year":"2014","journal-title":"Intensive Care Med."},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.3390\/jof3020024","article-title":"Revisiting species distribution and antifungal susceptibility of Candida bloodstream isolates from latin American medical centers.","volume":"3","author":"da Matta","year":"2017","journal-title":"J. Fungi."},{"key":"B10","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.micpath.2018.02.028","article-title":"Candida albicans-Biology, molecular characterization, pathogenicity, and advances in diagnosis and control\u2013An update.","volume":"17","author":"Dadar","year":"2018","journal-title":"Microb. Pathog."},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2016.00113","article-title":"Bioactive organocopper compound from Pseudomonas aeruginosa inhibits the growth of Xanthomonas citri subsp. citri.","volume":"7","author":"de Oliveira","year":"2016","journal-title":"Front Microbiol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"10192","DOI":"10.3390\/molecules170910192","article-title":"Synthetic approaches and pharmacological activity of 1, 3, 4-oxadiazoles: a review of the literature from 2000\u20132012.","volume":"17","author":"de Oliveira","year":"2012","journal-title":"Molecules"},{"key":"B13","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1016\/j.micpath.2018.09.026","article-title":"Emerging Candida species isolated from renal transplant recipients: species distribution and susceptibility profiles.","volume":"125","author":"Diba","year":"2018","journal-title":"Microb. Pathog."},{"key":"B14","doi-asserted-by":"publisher","first-page":"e1106","DOI":"10.1128\/AAC.01106-16","article-title":"In vitro activities of novel azole compounds ATTAF-1 and ATTAF-2 against fluconazole-susceptible and-resistant isolates of Candida species.","volume":"61","author":"Fakhim","year":"2017","journal-title":"Antimicrob. Agents Chemother."},{"key":"B15","doi-asserted-by":"publisher","first-page":"4015","DOI":"10.1007\/s00253-015-7223-8","article-title":"Structural and functional characterization of the recombinant thioredoxin reductase from Candida albicans as a potential target for vaccine and drug design.","volume":"100","author":"Godoy","year":"2016","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"549","DOI":"10.3390\/pathogens3030549","article-title":"Host pathogen relations: exploring animal models for fungal pathogens.","volume":"3","author":"Harwood","year":"2014","journal-title":"Pathogens"},{"key":"B17","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1089\/ars.2000.2.4-811","article-title":"Antioxidant function of thioredoxin and glutaredoxin systems.","volume":"2","author":"Holmgren","year":"2000","journal-title":"Antioxid. Redox Signal."},{"key":"B18","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1128\/AAC.44.3.614-618.2000","article-title":"Efficacy of FK463, a new lipopeptide antifungal agent, in mouse models of disseminated candidiasis and aspergillosis.","volume":"44","author":"Ikeda","year":"2000","journal-title":"Antimicrob. Agents Chemother."},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.3390\/jof3030041","article-title":"Strategies to reduce mortality in adult and neonatal candidemia in developing countries.","volume":"3","author":"Kaur","year":"2017","journal-title":"J. Fungi."},{"key":"B20","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1097\/CCM.0b013e318206c1ca","article-title":"Candida blood-stream infections in intensive care units: analysis of the extended prevalence of infection in intensive care unit study.","volume":"39","author":"Kett","year":"2011","journal-title":"Crit. Care Med."},{"key":"B21","article-title":"Composi\u00e7\u00e3o Farmac\u00eautica Baseada em Compostos 1,3,4-Oxadiaz\u00f3licos e seu uso na Prepara\u00e7\u00e3o de Medicamentos para Tratamento de Infec\u00e7\u00f5es Sist\u00eamicas, BR 10 2018 009020 8","author":"Kioshima","year":"2018"},{"key":"B22","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1128\/aac.42.5.1207","article-title":"Influence of test conditions on antifungal time-kill curve results: proposal for standardized methods.","volume":"42","author":"Klepser","year":"1998","journal-title":"Antimicrob. Agents Chemother."},{"key":"B23","doi-asserted-by":"publisher","first-page":"182","DOI":"10.2174\/157489107782497317","article-title":"Antifungal drug discovery, six new molecules patented after 10 years of feast: why do we need new patented drugs apart from new strategies?","volume":"2","author":"Krcmery","year":"2007","journal-title":"Recent Pat. Antiinfect. Drug Discov."},{"key":"B24","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1093\/jac\/dkq530","article-title":"Novel high-throughput screen against Candida albicans identifies antifungal potentiators and agents effective against biofilms.","volume":"66","author":"LaFleur","year":"2011","journal-title":"J. Antimicrob. Chemother."},{"key":"B25","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.bmc.2012.10.058","article-title":"Design, synthesis and characterization of novel 1, 2-benzisothiazol-3 (2H)-one and 1, 3, 4-oxadiazole hybrid derivatives: potent inhibitors of Dengue and West Nile virus NS2B\/NS3 proteases.","volume":"21","author":"Lai","year":"2013","journal-title":"Bioorg. Med. Chem."},{"key":"B26","doi-asserted-by":"publisher","first-page":"i4","DOI":"10.1093\/jac\/dkx444","article-title":"Changes in the epidemiological landscape of invasive candidiasis.","volume":"73","author":"Lamoth","year":"2018","journal-title":"J. Antimicrob. Chemother."},{"key":"B27","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1093\/infdis\/150.2.278","article-title":"Liposome-encapsulated amphotericin B for treatment of disseminated candidiasis in neutropenic mice.","volume":"150","author":"Lopez-Berestein","year":"1984","journal-title":"J. Infect. Dis."},{"key":"B28","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1128\/aac.42.5.1105","article-title":"Pharmacodynamics of fluconazole in a murine model of systemic candidiasis.","volume":"42","author":"Louie","year":"1998","journal-title":"Antimicrob. Agents Chemother."},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioorg.2019.103060","article-title":"New potent antifungal triazole alcohols containing N-benzylpiperazine carbodithioate moiety: synthesis, in vitro evaluation and in silico study.","volume":"12","author":"Mahmoudi","year":"2019","journal-title":"Bioorg. Chem."},{"key":"B30","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/s0300-483x(97)00151-0","article-title":"The sensitivity and specificity of the MTS tetrazolium assay for detecting the in vitro cytotoxicity of 20 chemicals using human cell lines.","volume":"124","author":"Malich","year":"1997","journal-title":"Toxicology"},{"key":"B31","doi-asserted-by":"publisher","first-page":"555","DOI":"10.2174\/1389557516666160118112103","article-title":"The mechanistic targets of antifungal agents: an overview.","volume":"16","author":"Mazu","year":"2016","journal-title":"Mini Rev. Med. Chem."},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-04462-6","article-title":"Potent in vitro and in vivo antifungal activity of a small molecule host defense peptide mimic through a membrane-active mechanism.","volume":"7","author":"Menzel","year":"2017","journal-title":"Sci. Rep."},{"key":"B33","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1128\/EC.4.2.487-489.2005","article-title":"Thioredoxin reductase is essential for viability in the fungal pathogen cryptococcus neoformans.","volume":"4","author":"Missall","year":"2005","journal-title":"Eukaryot. Cell"},{"key":"B34","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1007\/s12275-016-5628-4","article-title":"The development of fluconazole resistance in Candida albicans\u2013an example of microevolution of a fungal pathogen.","volume":"54","author":"Morschh\u00e4user","year":"2016","journal-title":"J. Microbiol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"987","DOI":"10.4155\/fmc-2017-0295","article-title":"Discovery of benzylthio analogs of fluconazole as potent antifungal agents.","volume":"10","author":"Motahari","year":"2018","journal-title":"Future Med. Chem."},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1093\/mmy\/myy107","article-title":"Virulence and susceptibility patterns of clinical Candida spp. isolates from a tertiary hospital, Tanzania.","author":"Mushi","year":"2018","journal-title":"Med. Mycol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"596","DOI":"10.2174\/1573406411309040014","article-title":"New quinolinyl\u20131, 3, 4\u2013oxadiazoles: synthesis, in vitro antibacterial, antifungal and antituberculosis studies.","volume":"9","author":"Patel","year":"2013","journal-title":"Med. Chem."},{"key":"B38","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.1016\/j.amjmed.2011.11.001","article-title":"Antifungal drug resistance: mechanisms, epidemiology, and consequences for treatment.","volume":"125","author":"Pfaller","year":"2012","journal-title":"Am. J. Med."},{"key":"B39","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3109\/10408410903241444","article-title":"Epidemiology of invasive mycoses in North America.","volume":"36","author":"Pfaller","year":"2010","journal-title":"Crit. Rev. Microbiol."},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0007441","article-title":"Antifungal activity of two oxadiazole compounds for the paracoccidioidomycosis treatment.","volume":"13","author":"Rodrigues-Vendramini","year":"2019","journal-title":"PLoS Negl. Trop. Dis."},{"key":"B41","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.2217\/fmb-2017-0065","article-title":"A new small-molecule KRE2 inhibitor against invasive Candida parapsilosis infection.","volume":"12","author":"Salci","year":"2017","journal-title":"Future Microbiol."},{"key":"B42","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1111\/myc.12330","article-title":"Antifungal drug resistance among Candida species: mechanisms and clinical impact.","volume":"58","author":"Sanguinetti","year":"2015","journal-title":"Mycoses"},{"key":"B43","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ejmech.2017.12.067","article-title":"Synthesis and antimicrobial activity of pyrimidinyl 1, 3, 4-oxadiazoles, 1, 3, 4-thiadiazoles and 1, 2, 4-triazoles.","volume":"145","author":"Sekhar","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"B44","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.ejim.2016.08.020","article-title":"Epidemiology and outcome of candidemia in internal medicine wards: a regional study in Italy.","volume":"34","author":"Tedeschi","year":"2016","journal-title":"Eur. J. Intern. Med."},{"key":"B45","doi-asserted-by":"publisher","first-page":"27259","DOI":"10.1074\/jbc.M704298200","article-title":"The thioredoxin system of the filamentous fungus Aspergillus nidulans: impact on development and oxidative stress response.","volume":"282","author":"Th\u00f6n","year":"2007","journal-title":"J. Biol. Chem."},{"key":"B46","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1128\/AAC.49.3.963-972.2005","article-title":"Small-molecule inhibitors of the budded-to-hyphal-form transition in the pathogenic yeast Candida albicans.","volume":"49","author":"Toenjes","year":"2005","journal-title":"Antimicrob. Agents Chemother."},{"key":"B47","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.compbiolchem.2017.12.013","article-title":"Identification of potential inhibitors against nuclear Dam1 complex subunit Ask1 of Candida albicans using virtual screening and MD simulations.","volume":"72","author":"Tripathi","year":"2018","journal-title":"Comput. Biol. Chem."},{"key":"B48","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.mycmed.2017.02.007","article-title":"Epidemiological and mycological characteristics of candidemia in Iran: a systematic review and meta-analysis.","volume":"27","author":"Vaezi","year":"2017","journal-title":"J. Mycol. Med."},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/713687","article-title":"Antifungal resistance and new strategies to control fungal infections.","volume":"2012","author":"Vandeputte","year":"2012","journal-title":"Int. J. Microbiol."},{"key":"B50","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.1080\/07391102.2017.1317025","article-title":"In silico high-throughput virtual screening and molecular dynamics simulation study to identify inhibitor for AdeABC efflux pump of Acinetobacter baumannii.","volume":"36","author":"Verma","year":"2018","journal-title":"J. Biomol. Struct. Dyn."},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0085836","article-title":"In vitro and in vivo activity of a novel antifungal small molecule against Candida infections.","volume":"9","author":"Wong","year":"2014","journal-title":"PLoS One."},{"key":"B52","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1080\/14756366.2018.1437156","article-title":"The discovery of novel HDAC3 inhibitors via virtual screening and in vitro bioassay.","volume":"33","author":"Xia","year":"2018","journal-title":"J. Enzyme Inhib. Med. Chem."}],"container-title":["Frontiers in Microbiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fmicb.2019.02130\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,12]],"date-time":"2019-09-12T04:28:32Z","timestamp":1568262512000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fmicb.2019.02130\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9,12]]},"references-count":52,"alternative-id":["10.3389\/fmicb.2019.02130"],"URL":"https:\/\/doi.org\/10.3389\/fmicb.2019.02130","relation":{},"ISSN":["1664-302X"],"issn-type":[{"value":"1664-302X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,9,12]]},"article-number":"2130"}}